Kathryn Lunga

Kathryn Lunga has a diverse work experience spanning multiple industries. Kathryn currently holds two roles at Sage Therapeutics, including one as the Director of Clinical Operations and Development. Kathryn joined the company in December 2021. Prior to that, Kathryn worked at Edstraordinary Kids Scholarship Foundation, Inc. as the CEO, starting in May 2015. Kathryn has also held positions at Gilead Sciences, where they served as the Director of Monitoring Excellence & Alliance Management from March 2020 to December 2021, and at Insmed Incorporated, where they were the Director of Clinical Operations from January 2018 to February 2020. Earlier in their career, Kathryn worked at Covance in various roles, including Associate Director of Pharmacovigilance & Drug Safety Services from September 2016 to January 2018, and Associate Director of Vendor Relationship Management from October 2013 to January 2018. Kathryn's experience demonstrates their expertise in clinical operations, vendor management, and non-profit leadership.

Kathryn Lunga completed their Bachelor's degree in Biology with a minor in Chemistry at Montclair State University from 1986 to 1991. Kathryn pursued further education in the field of Public Health and obtained a Master of Public Health (MPH) degree from Southern New Hampshire University, which they completed between 2021 and 2024.